Trump administration efforts to tamp down Medicare spending have spawned a high-stakes legal fight over bioengineered wound-care products used for purposes like covering diabetic sores. So-called skin substitutes are a massive cost driver in health care, and this will be a test of the federal government’s ability to actually bring spending down. Medicare officials’ change is expected to cut spending on the skin substitutes by an estimated $19.6 billion this year after outlays ballooned fortyfold in five years, accompanied by accusations of suspicious spending and patient harm. But biotech manufacturers are fighting back, in a case that could become a bellwether for the Trump administration’s broader moves to address waste and fraud in the medical system.
Read the full article: Billions at Stake in Growing Feud Over High-Tech Bandages //
Source: https://www.axios.com/2026/03/05/trump-medicare-bandages-diabetic